Connect with us

Government

Let’s kick-off 2022 with NNMX – a 1 CENT Low Float Runner awaiting FDA Approval for it’s COVID tests!

NANOMIX CORPORATION US SYMBOL: NNMX Last Price: .018  |  Website |  Latest News There’s no doubt that the main story in the world today as we enter 2022 is *once again*, COVID -19. This time, the world is combating an even more transmissive strain…

Published

on


NANOMIX CORPORATION

US SYMBOL: NNMX
Last Price: .018  |  Website |  Latest News

There’s no doubt that the main story in the world today as we enter 2022 is *once again*, COVID -19.

This time, the world is combating an even more transmissive strain known as the Omicron variant.

Sadly, infections are now reaching record highs across the globe – and in turn, tests have become much harder to come by – especially as they are now required more than ever to enter work, restaurants, and travel.

THE HEADLINES ARE EVERYWHERE:
Federal government has allocated at least $73 billion for COVID-19 testing, so where are the tests?
Up to a third of Israelis predicted to get COVID in next 3 weeks; tests running out
Madrid’s free COVID tests struggle with demand as infections hit new high

The moral of this story? WE NEED MORE TESTING…and FAST.  Only early diagnosis can help to prevent or stop an outbreak.

So there may be no better way to kick-off 2022 than with a stock that could actually have a REAL impact in combating this virus AND potentially save lives in the process.

Taking all this into account, Today’s New Years Kick-off Alert may be the most TIMELY alert we’ve ever released and it’s trading at under a mere 2 CENTS!!

WE ARE ISSUING AN IMMEDIATE ALERT ON NNMX!

Nanomix (NNMX) is developing mobile point-of-care diagnostics with its Nanomix eLab® System platform and assays that provide rapid, accurate, quantitative information for use in settings where time is critical to clinical decision-making and improved patient care.

The company’s products are designed to bring diagnostics to the point of initial patient interaction, whether in the hospital or in pre-hospital, remote or alternate-care settings, thereby enabling faster clinical decision-making and potentially treatment-in-place.

First up on the agenda? COVID-19.

Last month, NNMX submitted an Emergency Use Authorization Application with FDA for Approval/Clearance of it’s eLab COVID-19 rapid antigen test.

The company’s COVID-19 Antigen test cartridge is used with the Nanomix eLab Analyzer to provide electronically available results in 15 minutes.

Needless to say, Approval would have a Game-Changing impact on the NNMX.  And considering how fast the FDA has been approving vaccines for all ages lately, approval for this could also be IMMINENT!

“If authorized by the FDA, we believe our mobile point-of-care system will greatly increase accessibility to COVID-19 testing.”
David Ludvigson, President and Chief Executive Officer of Nanomix

Yet with all these major catalysts, the Street is still barely aware of this potential BLOCKBUSTER Situation as it trades at mere single-digit penny prices.

But [fname], that’s where we come in! Making you aware of NNMX’s potential here at the Ground Floor….*BEFORE* the rest catch on!

However…the “Ground Floor” may soon be in the rear view mirror as NNMX is currently displaying the creme de la creme of BULLISH Signals on it’s chart with an ULTRA-LOW FLOAT of just 72 Mil shares to boot!  Let’s dig in…

NNMX READY TO SURGE AGAIN WITH A GOLDEN CROSS BREAKOUT?
They call it the “Holy Grail” of Bullish Signals. The Rolls Royce of Chart patterns, if you will.

They’re rare.  They don’t happen often. BUT when they do…you can expect big things.

Yes, my friends…I’m talking about the GOLDEN CROSS.

What is a Golden Cross?
A Golden Cross is a basic technical indicator that occurs in the market when a short-term moving average (50-day) of an asset rises above a long-term moving average (200-day). When traders see a Golden Cross occur, they view this chart pattern as indicative of a strong bull market.

Many investors view the Golden Cross as a “holy grail” chart pattern. They consider it one of the most definitive signals of a bull market and, therefore, a strong buy signal. [Read More]

Now take a look at this beautiful Golden Cross chart below….

In addition to a Golden Cross, NNMX is displaying a Descending Triangle Pattern nearing its apex. So a direction to the upside or down could be imminent.

And with an Ultra-Low Float, NNMX is no stranger to quick TRIPLE DIGIT GAINS, having produced a tremendous 432% RALLY from .0091 to .0485 in early November!

KEEP IN MIND: A return back to 52-week highs of .07 would represent UPSIDE POTENTIAL OVER 280%!

If past performance is indicative of anything, NNMX could be on the heels of another MAJOR BREAKOUT, especially as the company awaits a potential FDA Clearance!

NNMX – THE NEXT LEADER IN MOBILE DIAGNOSTICS

The overall aim for NNMX is the development of a pipeline of tests designed to improve patient outcomes by making high-quality diagnostic information available within just minutes.

Founded in 2000 by UC Berkeley professors and award-winning physicists at Lawrence Berkeley National Laboratory, Marvin L. Cohen and Alex Zettl, NNMX is the leader in the development of mobile point-of-care (POC) diagnostics.

The Nanōmix eLab® system is a mobile immunoassay and chemistry diagnostic system designed for rapid Point-of-Care testing.

With this NNMX’s systems, healthcare professionals anywhere will have rapid access to quality diagnostic information while they interact with the patient!

The Nanōmix eLab offers the benefits of results in minutes, is low cost, and offers portability while providing accurate, quantitative results comparable to those provided by central lab testing.

The system utilizes a patented multi-plex test cartridge technology designed to broadly impact healthcare delivery by bringing diagnostics to the point of initial patient interaction, whether in the hospital or in pre-hospital, remote or alternate-care settings.

KEEP IN MIND: THIS IS A MASSIVE MARKET!

The global point of care diagnostics market size is projected to reach USD $50.6 BIL by 2025 from USD $29.5 BIL in 2020!

The company also recently announced confirmation of registration from the Medicines & Healthcare Products Regulatory Agency (MHRA) of the United Kingdom for the Nanomix eLab system and the S1 Panel Cartridge.

This registration is an important step in accelerating the introduction and availability of Nanomix products to markets and patients throughout the United Kingdom.

THE BOTTOM LINE
Even though the hot topic here is COVID-19 and NNMX’s ability to provide point-of-care rapid testing as they await FDA Authorization, I hope you can see that this company’s potential reaches much further than this virus.

Mobile Diagnostics is a huge BILLION DOLLAR rapid growth industry and NNMX’s technology could truly make them stand outs among the rest!

But for now…this is a TRUE FDA APPROVAL PLAY that must not be ignored.

With a History of Triple-Digit Gaining Rallies, a rare Golden Cross Bullish Chart signal, an Ultra-Low Float, and a potentially imminent News catalyst…there may be NO BETTER TIME for NNMX here at the Ground Floor UNDER 2 CENTS!

[fname], you’ve been put on notice BEFORE the rest of the Street are aware!

NNMX could be our BIGGEST New Years Kick-off Alert of ALL-TIME!

Make sure you put it on your screen RIGHT NOW and Follow on Twitter for all the Updates + Play-by-Play!

Good Trading,

Xavier Wright
Editor | WallStreetAlerts.org


Still need an Online Broker to place trades?
RobinHood & WeBull do NOT work!

Our Analysts HIGHLY recommend ETRADE

text alerts

.

IO

Home  |  Trading School  |  Twitter  |  ContactUNSUBSCRIBEView in Browser

Disclaimer2

We encourage all to read the SEC INVESTOR ALERT before reading our Newsletter.

WallStreetAlerts.org has NOT been compensated for this profile on Nanomix Corp. and does not expect to be in the future. WallStreetAlerts.org does not own any shares of NNMX. 

Disclaimer1

Read More

Continue Reading

International

There will soon be one million seats on this popular Amtrak route

“More people are taking the train than ever before,” says Amtrak’s Executive Vice President.

Published

on

While the size of the United States makes it hard for it to compete with the inter-city train access available in places like Japan and many European countries, Amtrak trains are a very popular transportation option in certain pockets of the country — so much so that the country’s national railway company is expanding its Northeast Corridor by more than one million seats.

Related: This is what it's like to take a 19-hour train from New York to Chicago

Running from Boston all the way south to Washington, D.C., the route is one of the most popular as it passes through the most densely populated part of the country and serves as a commuter train for those who need to go between East Coast cities such as New York and Philadelphia for business.

Veronika Bondarenko captured this photo of New York’s Moynihan Train Hall. 

Veronika Bondarenko

Amtrak launches new routes, promises travelers ‘additional travel options’

Earlier this month, Amtrak announced that it was adding four additional Northeastern routes to its schedule — two more routes between New York’s Penn Station and Union Station in Washington, D.C. on the weekend, a new early-morning weekday route between New York and Philadelphia’s William H. Gray III 30th Street Station and a weekend route between Philadelphia and Boston’s South Station.

More Travel:

According to Amtrak, these additions will increase Northeast Corridor’s service by 20% on the weekdays and 10% on the weekends for a total of one million additional seats when counted by how many will ride the corridor over the year.

“More people are taking the train than ever before and we’re proud to offer our customers additional travel options when they ride with us on the Northeast Regional,” Amtrak Executive Vice President and Chief Commercial Officer Eliot Hamlisch said in a statement on the new routes. “The Northeast Regional gets you where you want to go comfortably, conveniently and sustainably as you breeze past traffic on I-95 for a more enjoyable travel experience.”

Here are some of the other Amtrak changes you can expect to see

Amtrak also said that, in the 2023 financial year, the Northeast Corridor had nearly 9.2 million riders — 8% more than it had pre-pandemic and a 29% increase from 2022. The higher demand, particularly during both off-peak hours and the time when many business travelers use to get to work, is pushing Amtrak to invest into this corridor in particular.

To reach more customers, Amtrak has also made several changes to both its routes and pricing system. In the fall of 2023, it introduced a type of new “Night Owl Fare” — if traveling during very late or very early hours, one can go between cities like New York and Philadelphia or Philadelphia and Washington. D.C. for $5 to $15.

As travel on the same routes during peak hours can reach as much as $300, this was a deliberate move to reach those who have the flexibility of time and might have otherwise preferred more affordable methods of transportation such as the bus. After seeing strong uptake, Amtrak added this type of fare to more Boston routes.

The largest distances, such as the ones between Boston and New York or New York and Washington, are available at the lowest rate for $20.

Read More

Continue Reading

International

The next pandemic? It’s already here for Earth’s wildlife

Bird flu is decimating species already threatened by climate change and habitat loss.

I am a conservation biologist who studies emerging infectious diseases. When people ask me what I think the next pandemic will be I often say that we are in the midst of one – it’s just afflicting a great many species more than ours.

I am referring to the highly pathogenic strain of avian influenza H5N1 (HPAI H5N1), otherwise known as bird flu, which has killed millions of birds and unknown numbers of mammals, particularly during the past three years.

This is the strain that emerged in domestic geese in China in 1997 and quickly jumped to humans in south-east Asia with a mortality rate of around 40-50%. My research group encountered the virus when it killed a mammal, an endangered Owston’s palm civet, in a captive breeding programme in Cuc Phuong National Park Vietnam in 2005.

How these animals caught bird flu was never confirmed. Their diet is mainly earthworms, so they had not been infected by eating diseased poultry like many captive tigers in the region.

This discovery prompted us to collate all confirmed reports of fatal infection with bird flu to assess just how broad a threat to wildlife this virus might pose.

This is how a newly discovered virus in Chinese poultry came to threaten so much of the world’s biodiversity.

H5N1 originated on a Chinese poultry farm in 1997. ChameleonsEye/Shutterstock

The first signs

Until December 2005, most confirmed infections had been found in a few zoos and rescue centres in Thailand and Cambodia. Our analysis in 2006 showed that nearly half (48%) of all the different groups of birds (known to taxonomists as “orders”) contained a species in which a fatal infection of bird flu had been reported. These 13 orders comprised 84% of all bird species.

We reasoned 20 years ago that the strains of H5N1 circulating were probably highly pathogenic to all bird orders. We also showed that the list of confirmed infected species included those that were globally threatened and that important habitats, such as Vietnam’s Mekong delta, lay close to reported poultry outbreaks.

Mammals known to be susceptible to bird flu during the early 2000s included primates, rodents, pigs and rabbits. Large carnivores such as Bengal tigers and clouded leopards were reported to have been killed, as well as domestic cats.

Our 2006 paper showed the ease with which this virus crossed species barriers and suggested it might one day produce a pandemic-scale threat to global biodiversity.

Unfortunately, our warnings were correct.

A roving sickness

Two decades on, bird flu is killing species from the high Arctic to mainland Antarctica.

In the past couple of years, bird flu has spread rapidly across Europe and infiltrated North and South America, killing millions of poultry and a variety of bird and mammal species. A recent paper found that 26 countries have reported at least 48 mammal species that have died from the virus since 2020, when the latest increase in reported infections started.

Not even the ocean is safe. Since 2020, 13 species of aquatic mammal have succumbed, including American sea lions, porpoises and dolphins, often dying in their thousands in South America. A wide range of scavenging and predatory mammals that live on land are now also confirmed to be susceptible, including mountain lions, lynx, brown, black and polar bears.

The UK alone has lost over 75% of its great skuas and seen a 25% decline in northern gannets. Recent declines in sandwich terns (35%) and common terns (42%) were also largely driven by the virus.

Scientists haven’t managed to completely sequence the virus in all affected species. Research and continuous surveillance could tell us how adaptable it ultimately becomes, and whether it can jump to even more species. We know it can already infect humans – one or more genetic mutations may make it more infectious.

At the crossroads

Between January 1 2003 and December 21 2023, 882 cases of human infection with the H5N1 virus were reported from 23 countries, of which 461 (52%) were fatal.

Of these fatal cases, more than half were in Vietnam, China, Cambodia and Laos. Poultry-to-human infections were first recorded in Cambodia in December 2003. Intermittent cases were reported until 2014, followed by a gap until 2023, yielding 41 deaths from 64 cases. The subtype of H5N1 virus responsible has been detected in poultry in Cambodia since 2014. In the early 2000s, the H5N1 virus circulating had a high human mortality rate, so it is worrying that we are now starting to see people dying after contact with poultry again.

It’s not just H5 subtypes of bird flu that concern humans. The H10N1 virus was originally isolated from wild birds in South Korea, but has also been reported in samples from China and Mongolia.

Recent research found that these particular virus subtypes may be able to jump to humans after they were found to be pathogenic in laboratory mice and ferrets. The first person who was confirmed to be infected with H10N5 died in China on January 27 2024, but this patient was also suffering from seasonal flu (H3N2). They had been exposed to live poultry which also tested positive for H10N5.

Species already threatened with extinction are among those which have died due to bird flu in the past three years. The first deaths from the virus in mainland Antarctica have just been confirmed in skuas, highlighting a looming threat to penguin colonies whose eggs and chicks skuas prey on. Humboldt penguins have already been killed by the virus in Chile.

A colony of king penguins.
Remote penguin colonies are already threatened by climate change. AndreAnita/Shutterstock

How can we stem this tsunami of H5N1 and other avian influenzas? Completely overhaul poultry production on a global scale. Make farms self-sufficient in rearing eggs and chicks instead of exporting them internationally. The trend towards megafarms containing over a million birds must be stopped in its tracks.

To prevent the worst outcomes for this virus, we must revisit its primary source: the incubator of intensive poultry farms.

Diana Bell does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Read More

Continue Reading

International

This is the biggest money mistake you’re making during travel

A retail expert talks of some common money mistakes travelers make on their trips.

Published

on

Travel is expensive. Despite the explosion of travel demand in the two years since the world opened up from the pandemic, survey after survey shows that financial reasons are the biggest factor keeping some from taking their desired trips.

Airfare, accommodation as well as food and entertainment during the trip have all outpaced inflation over the last four years.

Related: This is why we're still spending an insane amount of money on travel

But while there are multiple tricks and “travel hacks” for finding cheaper plane tickets and accommodation, the biggest financial mistake that leads to blown travel budgets is much smaller and more insidious.

A traveler watches a plane takeoff at an airport gate.

Jeshoots on Unsplash

This is what you should (and shouldn’t) spend your money on while abroad

“When it comes to traveling, it's hard to resist buying items so you can have a piece of that memory at home,” Kristen Gall, a retail expert who heads the financial planning section at points-back platform Rakuten, told Travel + Leisure in an interview. “However, it's important to remember that you don't need every souvenir that catches your eye.”

More Travel:

According to Gall, souvenirs not only have a tendency to add up in price but also weight which can in turn require one to pay for extra weight or even another suitcase at the airport — over the last two months, airlines like Delta  (DAL) , American Airlines  (AAL)  and JetBlue Airways  (JBLU)  have all followed each other in increasing baggage prices to in some cases as much as $60 for a first bag and $100 for a second one.

While such extras may not seem like a lot compared to the thousands one might have spent on the hotel and ticket, they all have what is sometimes known as a “coffee” or “takeout effect” in which small expenses can lead one to overspend by a large amount.

‘Save up for one special thing rather than a bunch of trinkets…’

“When traveling abroad, I recommend only purchasing items that you can't get back at home, or that are small enough to not impact your luggage weight,” Gall said. “If you’re set on bringing home a souvenir, save up for one special thing, rather than wasting your money on a bunch of trinkets you may not think twice about once you return home.”

Along with the immediate costs, there is also the risk of purchasing things that go to waste when returning home from an international vacation. Alcohol is subject to airlines’ liquid rules while certain types of foods, particularly meat and other animal products, can be confiscated by customs. 

While one incident of losing an expensive bottle of liquor or cheese brought back from a country like France will often make travelers forever careful, those who travel internationally less frequently will often be unaware of specific rules and be forced to part with something they spent money on at the airport.

“It's important to keep in mind that you're going to have to travel back with everything you purchased,” Gall continued. “[…] Be careful when buying food or wine, as it may not make it through customs. Foods like chocolate are typically fine, but items like meat and produce are likely prohibited to come back into the country.

Related: Veteran fund manager picks favorite stocks for 2024

Read More

Continue Reading

Trending